*ST莫高(600543) - 2025 Q2 - 季度业绩预告

Gansu Mogao Industrial Development Co., Ltd. Announcement on Preliminary Loss for the First Half of 2025 Current Period Performance Forecast The company anticipates a significant net loss for the first half of 2025, with unaudited figures showing a substantial increase in losses compared to the prior year 2025 H1 Performance Forecast Details | Metric | 2025 H1 Forecast | Change from Prior-Year Period | | :--- | :--- | :--- | | Net Profit Attributable to Shareholders | -25 million to -37 million RMB | Loss increased by 15.77 million to 27.77 million RMB | | Net Profit after Non-recurring Items | -25 million to -37 million RMB | Loss increased by 14.98 million to 26.98 million RMB | - The applicable period for this performance forecast is from January 1, 2025, to June 30, 2025[3] - The preliminary performance data has not been audited by a certified public accountant[5] Prior-Year Period Performance Review The company reported a net loss in the first half of 2024, with key metrics indicating negative profitability and earnings per share 2024 H1 Key Financial Data | Metric | Amount | | :--- | :--- | | Total Profit | -9.29 million RMB | | Net Profit Attributable to Shareholders | -9.23 million RMB | | Net Profit after Non-recurring Items | -10.02 million RMB | | Earnings Per Share | -0.03 RMB | Analysis of Reasons for the Preliminary Loss The widening loss is attributed to persistent underperformance across all core business segments, including wine, degradable materials, pharmaceuticals, and film bags - The company's main business segments all underperformed during the reporting period[8]: - Wine business: Continued to incur losses due to the sluggish domestic market - Degradable materials business: Failed to reverse losses as the main product, PBAT, faced intense market competition - Pharmaceutical business: Profitability declined due to a year-over-year decrease in both production volume and selling price of its core product, Compound Glycyrrhiza Tablets - Film bag business: As a new venture with a short operational history, it remains in a loss-making phase Risk Warnings and Other Disclosures The company confirms no major uncertainties affecting this forecast but advises that final figures will be detailed in the official semi-annual report - The company states that there are no material uncertainties that would affect the accuracy of this performance forecast[9] - Investors are advised that the forecast data is preliminary and the final financial data will be subject to the 2025 semi-annual report, urging caution regarding investment risks[10]